Concerta and Sensory disturbance - a phase IV clinical study of FDA data
Summary:
Sensory disturbance is reported as a side effect among people who take Concerta (methylphenidate hydrochloride), especially for people who are female, 20-29 old, have been taking the drug for 1 - 6 months also take Ritalin, and have Cataplexy.
The phase IV clinical study analyzes which people have Sensory disturbance when taking Concerta. It is created by eHealthMe based on reports of 20,995 people who have side effects when taking Concerta from the FDA, and is updated regularly.
What is Concerta?
Concerta has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 25,040 Concerta users. Check the latest studies of Concerta.
What is Sensory disturbance?
Sensory disturbance (sense disturbance) is found to be associated with 1,095 drugs and 1,187 conditions by eHealthMe. Check the latest studies of Sensory disturbance.
20,995 people reported to have side effects when taking Concerta.
Among them, 40 people (0.19%) have Sensory disturbance.

Among these 40 people:
How long have people been on Concerta when they have Sensory disturbance? *
- < 1 month: 0.0 %
- 1 - 6 months: 50 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 50 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Sensory disturbance when taking Concerta? *
- female: 55.26 %
- male: 44.74 %
What is the age of people who have Sensory disturbance when taking Concerta? *
- 0-1: 0.0 %
- 2-9: 4 %
- 10-19: 20 %
- 20-29: 36 %
- 30-39: 16 %
- 40-49: 16 %
- 50-59: 4 %
- 60+: 4 %
What are other drugs people take besides Concerta? *
- Ritalin: 10 people, 25.00%
- Naltrexone: 5 people, 12.50%
- Cholestyramine: 5 people, 12.50%
- Cymbalta: 5 people, 12.50%
- Diflucan: 5 people, 12.50%
- Orap: 5 people, 12.50%
- Abilify: 5 people, 12.50%
- Xywav: 5 people, 12.50%
- Zyprexa: 4 people, 10.00%
- Ondansetron Hydrochloride: 4 people, 10.00%
What are other side effects people have besides Sensory disturbance? *
- Stress And Anxiety: 9 people, 22.50%
- Memory Loss: 8 people, 20.00%
- Fatigue (feeling of tiredness): 7 people, 17.50%
- Headache (pain in head): 7 people, 17.50%
- Weakness: 6 people, 15.00%
- Weight Increased: 5 people, 12.50%
- Disturbance In Attention: 5 people, 12.50%
- Dyspnea (difficult or laboured breathing): 5 people, 12.50%
- Craniocerebral Injury (injury to cranium and brain): 5 people, 12.50%
- Fungal Skin Infection: 5 people, 12.50%
What are the existing conditions these people have? *
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 15.00%
- Psychotic Disorder: 5 people, 12.50%
- Drowsiness: 5 people, 12.50%
- Personality Disorder: 3 people, 7.50%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 5.00%
- Emotional Disorder: 2 people, 5.00%
- Stress And Anxiety: 1 person, 2.50%
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 2.50%
- Pain: 1 person, 2.50%
- Migraine (headache): 1 person, 2.50%
* Approximation only. Some reports may have incomplete information.
Do you take Concerta and have Sensory disturbance?
- Check whether Sensory disturbance is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Concerta:
- Concerta (25,040 reports)
Sensory disturbance treatments and more:
- Sensory disturbance (19,192 reports)
How severe was Sensory disturbance and when was it recovered:
Expand to all the drugs that have ingredients of methylphenidate hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Concerta:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Sensory disturbance:
- Sensory disturbance (1,095 drugs)
Browse all the conditions that are associated with Sensory disturbance:
- Sensory disturbance (1,187 conditions)
Related publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on methylphenidate hydrochloride (the active ingredients of Concerta) and Concerta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Actonel cause Vitreous Detachment? - 8 seconds ago
- Could Bactroban cause Weight Loss? - 14 seconds ago
- Ashwanga vs. Rozerem, side effect and effectiveness comparison - 15 seconds ago
- Could Methylphenidate cause Rosacea? - 15 seconds ago
- T-Cell Type Acute Leukaemia and Ards (Acute Respiratory Distress Syndrome) - 16 seconds ago
- Could Mounjaro cause Dehydration? - 20 seconds ago
- Could Boron cause Nausea? - 21 seconds ago
- Drug interactions of Estradiol and Prednisolone Acetate - 22 seconds ago
- How effective is Clopidogrel for Stroke? - 35 seconds ago
- Folic Acid vs. Biotin, side effect and effectiveness comparison - 36 seconds ago